Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer

Figure 5

Comparison of ROC curves of alteration of immune cells, cytokines, or inflammation-based indexes, for predicting OS (a) and PFS (b) in patients with LAPC after IRE therapy. ROC: receiver operating characteristic; OS: overall survival; PFS: progression-free survival; LAPC: locally advanced pancreatic cancer; IRE: irreversible electroporation.

(a)

(b)